Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

GAUTAM GEORGE

Allopathic & Osteopathic Physicians Internal Medicine Pulmonary Disease

NPI
1912252032
CMS profile
313234
Location
CAMBRIDGE, MA

General Payments · PY2022–2024

$29,540.52

  • Reported across 54 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$6,449.13

14 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

By paying entity

PY2024 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2022 $5,644.29 14
PY2023 $17,447.10 26
PY2024 $6,449.13 14

Payment records · PY2024 (14)

Sorted by paying entity, then date · as published by CMS

Program year 2024 20222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Amgen Inc. $24.56 04/15/2024 Food and Beverage Undisputed 01/23/2026 1111582308 CMS
AstraZeneca Pharmaceuticals LP $13.83 01/22/2024 Food and Beverage Undisputed 01/23/2026 1104744359 CMS
AstraZeneca Pharmaceuticals LP $23.47 08/05/2024 Food and Beverage Undisputed 01/23/2026 1105641228 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $25.72 05/13/2024 Food and Beverage Undisputed 01/23/2026 1118231616 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $2,770.00 09/20/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1118231620 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $22.10 10/28/2024 Food and Beverage Undisputed 01/23/2026 1118231612 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $22.23 10/28/2024 Food and Beverage Undisputed 01/23/2026 1118231614 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $631.75 10/28/2024 Travel and Lodging Undisputed 01/23/2026 1118231618 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $2,770.00 12/02/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1118231622 CMS
Genentech USA, Inc. $18.79 01/22/2024 Food and Beverage Undisputed 01/23/2026 1133013681 CMS
GlaxoSmithKline, LLC. $23.10 08/29/2024 Food and Beverage Undisputed 01/23/2026 1116480757 CMS
GlaxoSmithKline, LLC. $24.18 10/30/2024 Food and Beverage Undisputed 01/23/2026 1116349398 CMS
GlaxoSmithKline, LLC. $21.52 12/09/2024 Food and Beverage Undisputed 01/23/2026 1116348278 CMS
United Therapeutics Corporation $57.88 09/07/2024 Food and Beverage Undisputed 01/23/2026 1149470410 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.